How Much Dividend Does MannKind Corporation (MNKD) Pay?


MannKind Corporation (NASDAQ:MNKD) finished Thursday with a subtraction of -$0.04 to close at $3.17, a downside of -1.25 percent. An average of 7,815,380 shares of common stock have been traded in the last five days. There was a fall of -$0.57 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 5,429,685 shares traded, while the 50-day average volume stands at 4,575,348.

MNKD stock has decreased by -18.30% in the last month. The company shares reached their 1-month lowest point of $3.09 on 09/22/22. With the stock rallying to its 52-week high on 06/08/22, shares of the company touched a low of $2.49 and a high of $5.44 in 52 weeks. It has reached a new high 3 times so far this year and lost -27.46% or -$1.20 in price. In spite of this, the price is down -41.73% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Insider Transactions

25 days have passed since MannKind Corporation (MNKD) last reported insider trading activity. Thomson David, who is EVP Genl Counsel & Secretary, most recently acquired $7,000 shares at $3.67 per share on Aug 29. In this transaction, the insider spent $25,690. EVP Endocrine Business Unit, Galindo Alejandro, disposed of 4,615 shares at a price of $3.85 on Aug 22. The insider now owns more than $17,771 worth of shares.

Valuation Metrics

MannKind Corporation (MNKD) stock’s beta is 1.73. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 13.03.

Financial Health

The quick ratio of MannKind Corporation for the three months ended March 30 was 2.90, and the current ratio was 3.20, indicating that the company is able to meet its debt obligations. Its gross profit as reported stood at $36.59 million compared to revenue of $75.44 million.

Earnings Surprise

For the three-month period that ended March 30, MannKind Corporation had $118.65 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$29.02 million in the quarter, while revenues were shrunk -22.4%. The analyst consensus anticipated MannKind Corporation’s latest quarter earnings to come in at -$0.1 per share, but it turned out to be -$0.1, a 0.00% surprise. For the quarter, EBITDA amounted to -$14.52 million. Shareholders own equity worth $257.34 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at MannKind Corporation (MNKD) price momentum. RSI 9-day as of the close on 22 September was 28.68%, suggesting the stock is oversold, with historical volatility in this time frame at 68.26%.

As of today, MNKD’s price is $3.36 -15.24% or -$0.57 from its 5-day moving average. MNKD is currently trading -20.55% lower than its 20-day SMA and +1.28% higher than its 100-day SMA. However, the stock’s current price level is -22.68% below the SMA50 and -26.11% below the SMA200.

The stochastic %K and %D were 4.89% and 9.33%, respectively, and the average true range (ATR) was 0.22. With the 14-day stochastic at 8.33% and the average true range at 0.23, the RSI (14) stands at 34.60%. The stock has reached -0.34 on the 9-day MACD Oscillator while the 14-day reading was at -0.41.

Analyst Ratings

RBC Capital Mkts launched coverage on MannKind Corporation (NASDAQ: MNKD) in its analyst report released on May 14, 2021. The firm assigned the stock a Sector perform rating.

What is MNKD’s price target for the next 12 months?

Analysts predict a range of price targets between $5.00 and $8.00, with a median target of $5.50. Taking a look at these predictions, the average price target given by analysts for MannKind Corporation (MNKD) stock is $6.00.


Please enter your comment!
Please enter your name here